{{cart_num}}
My CartCAS：760-78-1
Molecular Formula：C5H11NO2
Molecular Weight：117.15
Storage：Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year
Purity：≥98%
Appearance：White to off-white Solid
Qty：
Size：
| CAS | 760-78-1 |
| Name | DL-Norvaline |
| Molecular Formula | C5H11NO2 |
| Molecular Weight | 117.15 |
| Solubility | Soluble in Water |
| Purity | ≥98% |
| Appearance | White to off-white Solid |
| Storage | Powder:2-8℃，2 years;Insolvent(Mother Liquid):-20℃，6 months;-80℃，1 year |
| MDL | MFCD00064420 |
| SMILES | CCCC(C(=O)O)N |
| InChIKey | SNDPXSYFESPGGJ-UHFFFAOYSA-N |
| InChI | InChI=1S/C5H11NO2/c1-2-3-4(6)5(7)8/h4H，2-3，6H2，1H3，(H，7，8) |
| PubChem CID | 824 |
| Background | It is an amino acid. |
| Biological Activity | DL-Norvaline， a derivative of L-norvaline， L-norvaline is a non-competitive inhibitor of arginase. |
| IC50 | Human Endogenous Metabolite |
| Data Literature Source | [1]. Sosroseno W，et al. Arginase activity in a murine macrophage cell line (RAW264.7) stimulated with lipopolysaccharide from Actinobacillus actinomycetemcomitans. Oral Microbiol Immunol. 2006 Jun;21(3):145-50. [2]. El-Bassossy HM，et al. Arginase inhibition alleviates hypertension associated with diabetes: effect on endothelial dependent relaxation and NO production. Vascul Pharmacol. 2012 Nov-Dec;57(5-6):194-200. |
| Unit | Bottle |
| Specification | 100mg 250mg |
Remark：These protocols are for reference only. Solarbio does not independently validate these methods.
Note：
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download
